Skip to main content
Helix BioPharma Corp. logo

Helix BioPharma Corp. — Investor Relations & Filings

Ticker · HBP ISIN · CA4229102088 LEI · 9845005F4A1779D70B60 TSX Manufacturing
Open in API
Filings indexed 218 across all filing types
Latest filing 2026-02-05 Regulatory Filings
Country CA Canada
Listing TSX HBP

About Helix BioPharma Corp.

https://www.helixbiopharma.com/

Helix BioPharma Corp. is a clinical-stage biopharmaceutical company specializing in immune-oncology. The company is dedicated to developing innovative cancer treatments, focusing on hard-to-treat solid tumors. Helix employs a proprietary platform technology centered on bio-conjugates, which are designed to deliver precision targeting against malignant cells. This approach aims to create novel therapies that render challenging cancers vincible. The company's pipeline includes the clinical advancement of its lead candidate, L-DOS47.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release issued by Helix BioPharma Corp. announcing the extension of a research and exclusive option agreement with metaShape Pharma. It details the nature of the agreement, the strategic rationale, and provides background information on both companies. It does not fit into specific categories like financial reports, board changes, or shareholder voting results. As it is a general corporate announcement regarding a business agreement, it falls under the 'Regulatory Filings' (RNS) category, which serves as the fallback for general corporate news and announcements.
2026-02-05 English
News release - English.pdf
Report Publication Announcement Classification · 1% confidence The document is a short press release (under 5,000 characters) that announces the filing and availability of the company's interim financial statements and MD&A on SEDAR+. It does not contain the financial statements themselves, but rather serves as a notification of their publication. According to the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2025-12-16 English
52-109F1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 0% confidence The document is Form 52-109F1, the CEO’s “Certification of Annual Filings” under Canada’s National Instrument 52-109 attached to the annual filing. It is not the full annual report (10-K) or MD&A itself, nor an earnings release or AGM material, but a regulatory certificate filed with securities regulators. It does not announce the availability of any report, so it best fits the fallback “Regulatory Filings” category (RNS).
2025-10-29 English
52-109F1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 1% confidence The document is a Form 52-109F1 “Certification of Annual Filings” under Canadian National Instrument 52-109, signed by the CFO certifying the company’s annual filings (AIF, financial statements, MD&A) for the year ended July 31, 2025. It is a regulatory compliance certificate rather than the full annual report, audit opinion, or earnings release, and it does not merely announce the publication of a report. There is no dedicated category for certification forms, so this falls under the fallback “Regulatory Filings” category.
2025-10-29 English
Annual information form - English.pdf
Regulatory Filings Classification · 1% confidence The document is titled “Annual Information Form” filed on SEDAR, contains forward-looking statements, corporate structure, business description, risk factors, etc. It is a Canadian annual disclosure document distinct from a US Form 10-K, MD&A, or IFR, and there is no specific “AIF” category in our taxonomy. It is therefore best classified under the fallback “Regulatory Filings” category.
2025-10-29 English
News release - English.pdf
Earnings Release Classification · 1% confidence The document is a press release dated October 29, 2025 announcing the company’s fiscal 2025 year-end financial results (net loss, per share loss, R&D expenses, tables of financial data). It provides an initial announcement of the company’s yearly results rather than the full annual report, meeting the definition of an Earnings Release. Therefore, it should be classified as ER. FY 2025
2025-10-29 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.